» Articles » PMID: 22206249

CD248: Reviewing Its Role in Health and Disease

Overview
Specialty Pharmacology
Date 2011 Dec 31
PMID 22206249
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

CD248, also known as endosialin or tumor endothelial marker-1 (TEM-1), is a C-type lectin-like domain (CTLD) containing cell surface glycoprotein that is expressed by stromal cells of proliferating tissues during embryogenesis and postnatally in tumors and inflammatory lesions. Loss-of-function studies in mice support the notion that CD248 promotes tumor growth and inflammation, observations that are stimulating interest in evaluating this molecule as a therapeutic target. In spite of these advances, the mechanisms by which CD248 modulates cancer and inflammation remain largely enigmatic. This review highlights our current understanding of CD248, its structure, pattern of expression, regulation and function in various disease processes.

Citing Articles

CD248-expressing cancer-associated fibroblasts induce non-small cell lung cancer metastasis via Hippo pathway-mediated extracellular matrix stiffness.

Wu J, Zhang Q, Yang Z, Xu Y, Liu X, Wang X J Cell Mol Med. 2024; 28(16):e70025.

PMID: 39164826 PMC: 11335579. DOI: 10.1111/jcmm.70025.


TEM1/endosialin/CD248 promotes pathologic scarring and TGF-β activity through its receptor stability in dermal fibroblasts.

Hong Y, Lin Y, Cheng T, Lai C, Chang Y, Huang Y J Biomed Sci. 2024; 31(1):12.

PMID: 38254097 PMC: 10804696. DOI: 10.1186/s12929-024-01001-0.


Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches.

Lu S, Gan L, Lu T, Zhang K, Zhang J, Wu X Theranostics. 2024; 14(1):379-391.

PMID: 38164138 PMC: 10750205. DOI: 10.7150/thno.89495.


[Expression of endosialin in human hypertrophic scars and its regulation on fibroblast phenotype].

Zhang Q, Zhang L, Han D, Jiao X, Zheng Z, Guo K Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023; 39(12):1168-1174.

PMID: 38129304 PMC: 11630340. DOI: 10.3760/cma.j.cn501225-20231030-00154.


From bench to bedside: Cu/Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications.

Gnesin S, Chouin N, Cherel M, Dunn S, Schaefer N, Faivre-Chauvet A EJNMMI Res. 2023; 13(1):59.

PMID: 37314509 PMC: 10267050. DOI: 10.1186/s13550-023-01010-4.